Christopher Mills - Jul 1, 2023 Form 3 Insider Report for Renalytix plc (RNLX)

Role
Director, 10%+ Owner
Signature
/s/ Katie Kazem, Attorney-in-Fact
Stock symbol
RNLX
Transactions as of
Jul 1, 2023
Transactions value $
$0
Form type
3
Date filed
7/3/2023, 04:23 PM
Next filing
Nov 22, 2023

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each representing two Ordinary Shares.
F2 The securities are directly held by North Atlantic Smaller Companies Investment Trust plc ("North Atlantic"). The Reporting Person is the Partner and Chief Investment Officer of Harwood Capital LLP ("Harwood"). Harwood is the Investment Manager to North Atlantic. The Reporting Person disclaims beneficial ownership of the securities held by North Atlantic except to the extent of his pecuniary interest therein.
F3 The securities are directly held by Oryx International Growth Fund Limited ("Oryx"). The Reporting Person is the Partner and Chief Investment Officer of Harwood. Harwood is the investment adviser to Oryx. The Reporting Person disclaims beneficial ownership of the securities held by Oryx except to the extent of his pecuniary interest therein.
F4 The securities are directly held by Harwood. The Reporting Person is the Partner and Chief Investment Officer of Harwood. The Reporting Person disclaims beneficial ownership of the securities held by Harwood except to the extent of his pecuniary interest therein.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney